Back to the fridge
Screening & detection

Dense breasts, clearer view

Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)

Mann RM et al. · European Radiology · 2022

The big question

Breasts are made of fat and denser glandular and fibrous tissue. On a mammogram, dense tissue looks white, and so do tumors, so cancers can hide. Dense breasts also carry a higher risk of breast cancer. What should people with extremely dense breasts be offered?

What they did

The European Society of Breast Imaging (EUSOBI), a group of breast radiology experts, reviewed recent research. They focused on studies of MRI screening, especially the DENSE trial, a Dutch randomized trial in women with extremely dense breasts and a normal mammogram.

What they found

About 8% of people screened have extremely dense breasts. Mammograms catch 86 to 89% of cancers in mostly fatty breasts but only 62 to 68% in extremely dense breasts. In the DENSE trial, MRI found 16.5 extra cancers per 1,000 screens in the first round. Cancers showing up between screenings dropped from 5.0 to 0.8 per 1,000, about 84% fewer. EUSOBI now recommends telling women their density and offering MRI every 2 to 4 years to those aged 50 to 70 with extremely dense breasts.

Why it matters

Many people do not know their density. This gives them a reason to ask and a possible next step.

What it doesn't mean

These are European expert recommendations, not US rules. MRI also flags harmless findings that lead to extra tests, and it is not yet available everywhere. The experts stress shared decision-making with a doctor.

Read the original abstract
Breast density is an independent risk factor for the development of breast cancer and also decreases the sensitivity of mammography for screening. Consequently, women with extremely dense breasts face an increased risk of late diagnosis of breast cancer. These women are, therefore, underserved with current mammographic screening programs. The results of recent studies reporting on contrast-enhanced breast MRI as a screening method in women with extremely dense breasts provide compelling evidence that this approach can enable an important reduction in breast cancer mortality for these women and is cost-effective. Because there is now a valid option to improve breast cancer screening, the European Society of Breast Imaging (EUSOBI) recommends that women should be informed about their breast density. EUSOBI thus calls on all providers of mammography screening to share density information with the women being screened. In light of the available evidence, in women aged 50 to 70 years with extremely dense breasts, the EUSOBI now recommends offering screening breast MRI every 2 to 4 years. The EUSOBI acknowledges that it may currently not be possible to offer breast MRI immediately and everywhere and underscores that quality assurance procedures need to be established, but urges radiological societies and policymakers to act on this now. Since the wishes and values of individual women differ, in screening the principles of shared decision-making should be embraced. In particular, women should be counselled on the benefits and risks of mammography and MRI-based screening, so that they are capable of making an informed choice about their preferred screening method.

Abstract reproduced from Mann RM et al., European Radiology (2022), under a CC BY 4.0 license. Plain-English summary by Womanhattan.

This summary was written with AI assistance and checked against the original paper. It is for learning, not medical advice. Talk with your care team before changing anything about your health or treatment.